Mallinckrodt plagued by 'production issues,' falls about 9%

Mallinckrodt said it recently experienced temporary "production issues" with a third-party manufacturer supporting its immunotherapy platform, Therakos.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.